MM-102 - CAS 1417329-24-8
Catalog number: 1417329-24-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
MM-102, as a MLL1 mimetic, shows high binding affinities to WDR5 with IC50 of 2.9 nM and Ki of < 1 nM.
Publictions citing BOC Sciences Products
  • >> More
HMTase Inhibitor IX
1.Morphometric and meristic characteristics of the goldside loach Sabanejewia balcanica (Cobitidae) in Central Croatia.
Delić A1, Kucinić M, Bucar M, Lazar B, Mrakovcić M. Folia Biol (Krakow). 2003;51 Suppl:33-8.
We studied sixteen morphometric and eight meristic characteristics of forty-five goldside loaches from two rivers in central Croatia, the Bijela and the Petrinjcica, belonging to the Sava River basin. We found significant differences (P<0.01) in all the morphometric characteristics of the populations from these two rivers. While the mean total length (TL) of the goldside loache population from Petrinjcica (mean TL = 60.4 mm, min-max = 52.8 - 70.2 mm) is comparable with TL in other populations described in Europe, individuals from the Bijela seem to be significantly larger (mean TL = 91.8 mm; min-max = 76.4 mm- 102.4 mm) and are among the longest specimens in Europe. Although we can not be sure if this is a result of phenotype variability or some specific taxonomic quality, the position of the Bijela on the old isolated massif of Mt Papuk may have led to the specific morphometric characteristics of this goldside loach population.
2.Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney.
Cai M1, Bompada P2, Atac D2, Laakso M3, Groop L4, De Marinis Y5. Biochem Biophys Res Commun. 2016 Jan 1;469(1):108-13. doi: 10.1016/j.bbrc.2015.11.079. Epub 2015 Nov 22.
Diabetes nephropathy (DN) is the leading cause of end stage renal disease and it affects up to 40% of diabetic patients. In addition to hyperglycemia, genetic factors are thought to contribute to the development of DN, but few if any genetic factors have been convincingly linked to DN. Other possible mechanisms may involve epigenetic regulation of glucose-stimulated gene activity which was suggested to explain long-term effects of poor glycemic control on risk of diabetic complications, often referred to as metabolic memory. Osteopontin (OPN) is one of the genes upregulated in kidneys from diabetic mouse models as well as humans with DN, and suggested to play an important role in the pathogenesis of DN. In this study, we demonstrated that OPN gene expression is upregulated in the kidneys of a hyperglycemia diabetes mouse model SUR1-E1506K, and glucose-stimulated OPN gene expression is strongly associated with increases in activating histone marks H3K9ac, H3K4me1 and H3K4me3 and decrease in inactivating mark H3K27me3 in the promoter region of OPN gene.
3.High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction.
Karatas H1, Townsend EC, Cao F, Chen Y, Bernard D, Liu L, Lei M, Dou Y, Wang S. J Am Chem Soc. 2013 Jan 16;135(2):669-82. doi: 10.1021/ja306028q. Epub 2012 Dec 27.
Mixed lineage leukemia 1 (MLL1) is a histone H3 lysine 4 (H3K4) methyltransferase, and targeting the MLL1 enzymatic activity has been proposed as a novel therapeutic strategy for the treatment of acute leukemia harboring MLL1 fusion proteins. The MLL1/WDR5 protein-protein interaction is essential for MLL1 enzymatic activity. In the present study, we designed a large number of peptidomimetics to target the MLL1/WDR5 interaction based upon -CO-ARA-NH-, the minimum binding motif derived from MLL1. Our study led to the design of high-affinity peptidomimetics, which bind to WDR5 with K(i) < 1 nM and function as potent antagonists of MLL1 activity in a fully reconstituted in vitro H3K4 methyltransferase assay. Determination of co-crystal structures of two potent peptidomimetics in complex with WDR5 establishes their structural basis for high-affinity binding to WDR5. Evaluation of one such peptidomimetic, MM-102, in bone marrow cells transduced with MLL1-AF9 fusion construct shows that the compound effectively decreases the expression of HoxA9 and Meis-1, two critical MLL1 target genes in MLL1 fusion protein mediated leukemogenesis.
4.The anatomy of proximal femoral autografts for pelvic reconstruction: a cadaveric study.
Wang S1, Xiong J, Zhan C, Wang A, Chen Y, Jiang Q, Qiu Y. Surg Radiol Anat. 2012 May;34(4):305-9. doi: 10.1007/s00276-011-0914-7. Epub 2011 Dec 3.
PURPOSE: One important reconstruction procedure following pelvic tumor resection is ipsilateral femoral autograft reconstruction in which the autograft is transposed onto the defect and a conventional total hip replacement is implanted in the autograft. The purpose of this study is to provide anatomical evidence for this reconstruction by measurement of proximal femoral autografts.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HMTase Products

CAS 1621862-70-1 CPI-1205

(CAS: 1621862-70-1)

A highly potent and selective EZH2 inhibitor (biochemical IC50=2 nM, cellular EC50=32 nM)

CAS 1338466-77-5 EPZ004777

(CAS: 1338466-77-5)

EPZ004777 is a potent, selective inhibitor of DOT1L. Treatment of mixed lineage leukemia (MLL) cells with EPZ004777 selectively inhibits H3K79 methylation ...

SGC2085 HCl
(CAS: 1821908-49-9)

SGC2085, also called as GTPL9259, is a potent and selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor with an IC50 of 50 nM and more...

CAS 1238673-32-9 UNC0321

(CAS: 1238673-32-9)

UNC0321 is the first G9a inhibitor with picomolar potency and the most potent G9a inhibitor to date. Protein lysine methyltransferase G9a, which catalyzes methy...

CAS 1821908-48-8 SGC2085

(CAS: 1821908-48-8)

SGC2085, also called as GTPL9259, is a potent and selective Coactivator Associated Arginine Methyltransferase 1 (CARM1), which has an IC50 of 50 nM for CARM1 an...

CAS 1793053-37-8 LLY-507

(CAS: 1793053-37-8)

LLY-507, a lysine N-methyltransferase, is a cell-active, small molecule, and selective inhibitor of Protein-lysine Methyltransferase SMYD2 (IC50 = 15 nM), with ...

CAS 1417329-24-8 MM-102

(CAS: 1417329-24-8)

MM-102, as a MLL1 mimetic, shows high binding affinities to WDR5 with IC50 of 2.9 nM and Ki of < 1 nM.

CAS 6398-98-7 Amodiaquin dihydrochloride dihydrate

Amodiaquin dihydrochloride dihydrate
(CAS: 6398-98-7)

Amodiaquine, a 4-aminoquinoquinoline compound, has is a histamine N-methyltransferase inhibitor, used as an antimalarial and anti-inflammatory agent been used a...

CAS 935693-62-2 BIX-01294

(CAS: 935693-62-2)

BIX-01294, a diazepin-quinazolinamine derivative, is a selective inhibitor of G9a histone methyl transferase (G9a HMTase) that impairs G9a HMTase and generation...

CAS 1380288-87-8 EPZ-5676

(CAS: 1380288-87-8)

EPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity. Upon intravenous administration, EPZ-5676 specifical...

(CAS: 1687736-54-4)

SGC707 is a potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3) with IC50 and Kd of 31 nM and 53 nM, respecti...

(CAS: 1624117-53-8)

XY1 is a close analog of SGC707 that is completely inactive against PRMT3 at concentrations as high as 100 µM. It is intended to be used as a negative control f...

CAS 1380316-03-9 EPZ004777 hydrochloride

EPZ004777 hydrochloride
(CAS: 1380316-03-9)

EPZ004777 selectively inhibits cellular H3K79 methylation and inhibits expression of key MLL fusion target genes. Following DOT1L inhibition, EPZ004777 selectiv...

CAS 1314241-44-5 UNC 669

UNC 669
(CAS: 1314241-44-5)

(5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone is a selective inhibitor of malignant brain tumor (MBT).

CAS 1616391-65-1 EPZ015666

(CAS: 1616391-65-1)

EPZ015666 shows potent cellular activity that blocks symmetric dimethylation of SmD3 and inhibit proliferation of MCL cell lines (Z-138, Granta-519, Maver-1, Mi...

HLCL-61 hydrochloride
(CAS: 1158279-20-9)

The hydrochloride salt form of HLCL-61, an effective inhibitor of PRMT5, could probably useful in the treatment of acute myeloid leukemia.

CAS 1320288-19-4 UNC-0631

(CAS: 1320288-19-4)

CAS 432529-82-3 BCI-121

(CAS: 432529-82-3)

BCI-121, a SMYD3 inhibitor, induces a significant reduction in SMYD3 activity both in vitro and in CRC cells.

CAS 1415800-43-9 UNC1215

(CAS: 1415800-43-9)

UNC1215 is a potent, selective antagonist of L3MBTL3 with cellular activity. UNC1215 has an IC50 of 20 nM and > 100-fold selectivity over 13 HMTs and selected r...

CAS 1620401-82-2 UNC0379

(CAS: 1620401-82-2)

UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. UNC0379 is active in multiple biochemical assays. Its affinity t...

Chemical Structure

CAS 1417329-24-8 MM-102

Quick Inquiry

Verification code

Featured Items